| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/12/2009 | CN101506208A Pyrrolo isoquinolines as kinase inhibitors |
| 08/12/2009 | CN101506186A Substituted n-acyl homoserine lactones |
| 08/12/2009 | CN101506177A 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as JAK kinases inhibitors |
| 08/12/2009 | CN101505780A Treatment of development-related disorders |
| 08/12/2009 | CN101505758A Pharmaceutical containing thiazole derivative as active ingredient |
| 08/12/2009 | CN101505750A Sugar-free storage-stable antihistaminic syrups |
| 08/12/2009 | CN101503727A Hyriopsis cumingii enzymolysis polypeptide, as well as preparation and application thereof |
| 08/12/2009 | CN101503662A Microbial strain for antianaphylaxis symptom, composition thereof and method for producing interferon-gamma by using the microbial strain irritation cell |
| 08/12/2009 | CN101503356A Novel method for preparing high-purity chlorogenic acid |
| 08/12/2009 | CN101502641A Ciclosporin medicament composition for injection administration |
| 08/12/2009 | CN101502629A Chinese herbal compound preparation for treating systemic lupus erythematosus |
| 08/12/2009 | CN101502624A 36-flavor Glutinous rehmannia pill and capsule |
| 08/12/2009 | CN101502613A Body-strengthening fatigue-resisting lipid-lowering oral liquid and capsule |
| 08/12/2009 | CN101502607A Cordyceps sinensis and mushroom composition, Cordyceps sinensis and mushroom polysaccharide oral liquid, and preparation method thereof |
| 08/12/2009 | CN101502532A Application of triple spiral Dictyophora phalloidea polysaccharide |
| 08/12/2009 | CN101502516A Glipizide enteric-coated formulation composition and method for preparing the same |
| 08/12/2009 | CN101502515A Hydrochloride loratadine enteric-coated formulation composition and method for preparing the same |
| 08/12/2009 | CN101502495A Pemirolast Potassium and technique for producing the same |
| 08/12/2009 | CN100526307C Metalloproteinase inhibitors |
| 08/12/2009 | CN100525832C Chaperonin 10 immunosuppression |
| 08/12/2009 | CN100525799C Pharmaceutical composition for preventing and/or treating oral disease caused by microbe |
| 08/12/2009 | CN100525768C Novel compounds |
| 08/12/2009 | CN100525756C Coated ubenimex table |
| 08/11/2009 | US7572924 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/11/2009 | US7572900 Expression vector comprising breast cancer gene (BCL-2) nucleotide sequences for use as tool in treatment, diagnosis and prevention of cell proliferative disorders |
| 08/11/2009 | US7572883 Somatostatin-dopamine chimeric analogs |
| 08/11/2009 | US7572833 E.g., N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal stabilized with a lipid; improved absorption and penetration; treating ischemia, immune diseases, Alzheimer's disease, osteoporosis, brain disorders, eye diseases, osteoporosis |
| 08/11/2009 | US7572813 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| 08/11/2009 | US7572804 Macrolides |
| 08/11/2009 | US7572791 Long-term stability, extended delivery using a suitable reservoir; pumped or metered at a controlled rate; implantable or external pump device, pen style injection device; stable at physiologic temperatures for duration of therapeutic exposure; supply of therapeutically active material for up to 2 years |
| 08/11/2009 | US7572762 Materials and methods relating to the induction of apoptosis in target cells |
| 08/11/2009 | US7572605 1,2,3,tris(4-hydroxy-butyroyloxy)propane; enhance the uptake of the drug, deliver effective therapeutic doses in a time-delayed fashion, and target specific organs |
| 08/11/2009 | US7572466 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 08/11/2009 | US7572463 Oral dosage forms |
| 08/11/2009 | US7572454 From Canine Distemper Virus; vaccines; luteinizing hormone releasing hormone |
| 08/11/2009 | US7572442 Selected antibody compositions for binding to aminophospholipids |
| 08/11/2009 | US7572436 Thionin as an antineoplastic and immunostimulant |
| 08/11/2009 | CA2482551C 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists |
| 08/11/2009 | CA2449402C Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 08/11/2009 | CA2448825C Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/11/2009 | CA2447614C A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation |
| 08/11/2009 | CA2359772C Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 08/11/2009 | CA2328133C Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 08/11/2009 | CA2271248C Use of a notch ligand in immunotherapy |
| 08/08/2009 | CA2653300A1 Polyvalent vaccine against salmonid alphavirus infections |
| 08/06/2009 | WO2009097291A2 Canine influenza vaccines |
| 08/06/2009 | WO2009097120A1 Methods using immunomodulatory compounds for modulating level of cd59 |
| 08/06/2009 | WO2009096080A1 Piperidine derivative |
| 08/06/2009 | WO2009095796A2 Tapasin augmentation for enhanced immune response |
| 08/06/2009 | WO2009094850A1 Recombinant ganoderma lucidium immunomodulatory protein (rlz-8) and uses thereof |
| 08/06/2009 | WO2009094752A1 An anti-cancer cytotoxic monoclonal antibody |
| 08/06/2009 | WO2009094751A1 An anti-cancer cytotoxic monoclonal antibody |
| 08/06/2009 | WO2009094730A1 Vaccine compositions |
| 08/06/2009 | WO2009094717A2 A method of inducing tolerance to an allergen |
| 08/06/2009 | WO2009074950A3 Thiophene derivatives as agonists of s1p1/edg1 |
| 08/06/2009 | WO2009073146A3 Use of immunomodulatory compounds for the treatment of transverse myelitis, multiple sclerosis, and other disorders |
| 08/06/2009 | WO2009047791A3 Toll like receptor (tlr) signaling antagonist |
| 08/06/2009 | WO2009043522A3 Use of a peptide as a therapeutic agent |
| 08/06/2009 | WO2009043463A3 Use of gluten exorphin c : as a therapeutic agent |
| 08/06/2009 | WO2009033793A3 Pentagastrin as a therapeutic agent |
| 08/06/2009 | WO2009033721A3 Use of salusin beta alone or in combination with octreotide as a therapeutic agent |
| 08/06/2009 | WO2008109852A8 Compositions and methods for the prevention and treatment of autoimmune conditions |
| 08/06/2009 | US20090199306 Fucosyl transferase gene |
| 08/06/2009 | US20090197945 Method for Generating Reference Controls for Pharmacogenomic Testing |
| 08/06/2009 | US20090197914 Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them |
| 08/06/2009 | US20090197887 Piperazinylpiperidine derivatives as chemokine receptor antagonists |
| 08/06/2009 | US20090197867 Enantiomerically enriched imidazoazepinone compounds |
| 08/06/2009 | US20090197814 Chemically modified peptides derived from the chemokine CCL14 (HCC-1); replacement of the ultimate N-terminal amino acid of CCL14[9-74] by nonanoic acid (NNY) converts it into a potent agonist; inactivation of the chemokine receptor; antiinflammatory agents |
| 08/06/2009 | US20090197337 Methods for the production of multimeric proteins and related compositions |
| 08/06/2009 | US20090196921 Compositions Methods and Kits For Enhancing Immune Response To A Respiratory Condition |
| 08/06/2009 | US20090196888 Nucleic acids encoding recombinant 56 and 82 kDa antigents from gametocytes of Eimeria maxima and their uses |
| 08/06/2009 | US20090196876 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/06/2009 | US20090196856 Method for Generating Dendritic Cells Employing Decreased Temperature |
| 08/06/2009 | CA2713293A1 Piperidine derivative |
| 08/06/2009 | CA2712964A1 Tapasin augmentation for enhanced immune response |
| 08/06/2009 | CA2712881A1 Canine influenza vaccines |
| 08/06/2009 | CA2712724A1 Use of lenalidomide or pomalidomide for treating a disease associated with cd59 deficiency |
| 08/06/2009 | CA2711207A1 Recombinant ganoderma lucidium immunomodulatory protein (rlz-8) and uses thereof |
| 08/05/2009 | EP2085407A1 Treatment of idiopathic thrombocytopenic purpura |
| 08/05/2009 | EP2085389A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085388A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085387A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085095A1 Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart |
| 08/05/2009 | EP2085094A2 Application of aminopeptidases inhibitors and pharmaceutical preparations containing same |
| 08/05/2009 | EP2085090A2 Inhibitors of DNA immunostimulatory sequence activity |
| 08/05/2009 | EP2084188A2 Antibodies to lymphotoxin-alpha |
| 08/05/2009 | EP2083812A1 Use of arginase inhibitors in the treatment of asthma and allergic rhinitis |
| 08/05/2009 | EP1781606B1 Azetidine derivatives as ccr-3 receptor antagonists |
| 08/05/2009 | EP1771178B1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 08/05/2009 | EP1531822B1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
| 08/05/2009 | EP1512014B1 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
| 08/05/2009 | EP1509506B1 Pyridazine derivatives |
| 08/05/2009 | EP1503778B1 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| 08/05/2009 | EP1501797B1 3-(substituted amino)-1h-indole-2-carboxylic acid ester and 3-(substituted amino)-benzo[b]thiophene-2-carboxylic acid ester derivatives as interleukin-4 gene expression inhibitors |
| 08/05/2009 | EP1430085B1 Leukocyte inactivation module |
| 08/05/2009 | EP1407004B1 Ex-vivo priming for generating cd40-ligand specific cytotoxic t lymphocytes to treat autoimmune and allergic disease |
| 08/05/2009 | EP1357111B1 2-pyridone derivatives having affinity for cannabinoid type 2 receptor |
| 08/05/2009 | EP1286703B1 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 08/05/2009 | EP1253939B1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent |
| 08/05/2009 | EP1069907B1 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS |